Factors influencing treatment efficacy in patients with multiple and extensive drug resistant tuberculosis

Factors influencing treatment efficacy in patients with multiple and extensive drug resistant tuberculosis

The objective: to determine factors influencing treatment efficacy in patients with multiple (MDR) and extensive (XDR) drug resistant tuberculosis. Subjects and methods. The medical files of 107 tuberculosis patients (men – 75, women – 32) were analyzed, 17 of them were HIV positive. Those 107 patie...

Full description

Bibliographic Details
Main Authors:	I. S. Lapshina, B. U. Salikhov, T. V. Myakisheva, S. V. Kostromtsov, A. V. Paramonov, V. A. Аndreev
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2020-11-01
Series:	Туберкулез и болезни лёгких
Subjects:	туберкулез множественная/широкая лекарственная устойчивость хирургическое лечение туберкулез и вич-инфекция
Online Access:	https://www.tibl-journal.com/jour/article/view/1471

Similar Items

Drug susceptibility of M. tuberculosis in tuberculosis patients from various population groups in Khanty-Mansiyskiy Autonomous Region
by: Yu. V. Reshetnikova, et al.
Published: (2015-11-01)

Prevalence of Extensively Drug-Resistant Tuberculosis: a Descriptive Study
by: O. A. Pasechnik, et al.
Published: (2018-09-01)

EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01)

EXPERIENCE OF USING THE TB DRUG OF PERCHLOZON IN TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE IN BURYATIA REPUBLIC
by: S. V. Nikolaeva
Published: (2015-10-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)

Experience in treating drug-resistant tuberculosis in patients with HIV infection
by: A. I. Gordon, et al.
Published: (2014-12-01)

The short-course chemotherapy in the treatment of multiple drug resistant tuberculosis in children with different HIV status
by: E. Yu. Zorkaltseva, et al.
Published: (2019-09-01)

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ РИФАМПИЦИН-УСТОЙЧИВОГО ТУБЕРКУЛЕЗА В СОЧЕТАНИИ С СИНДРОМОМ ЗАВИСИМОСТИ ОТ АЛКОГОЛЯ
by: Ю. А. Шейфер, et al.
Published: (2023-03-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

EFFICACY OF PATIENT-ORIENTED CHEMOTHERAPY OF LOCAL TUBERCULOUS LESIONS IN THE CHILDREN EXPOSED TO MULTIPLE/EXTENSIVE DRUG RESISTANT TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2019-03-01)

Efcacy and safety of combination therapy with bedaquiline in a multimorbid HIV positive patient with multiple drug resistant tuberculosis
by: E. M. Zhukova, et al.
Published: (2022-07-01)

THE EPIDEMIC SITUATION OF TUBERCULOSIS AND HIV INFECTION IN THE PENITENTIARY FACILITIES OF RUSSIA
by: O. B. Nechaeva, et al.
Published: (2015-03-01)

A CLINICAL CASE OF EFFECTIVE TREATMENT OF EXTENSIVE DRUG RESISTANCE TUBERCULOSIS WITH NEW ANTI-TUBERCULOSIS DRUGS
by: M. V. Pаvlovа, et al.
Published: (2018-01-01)

TUBERCULOSIS CONTROL SITUATION IN TERRITORIES OF THE RUSSIAN FEDERATION SUPERVISED BY CENTRAL TUBERCULOSIS RESEARCH INSTITUTE, 2014-2015
by: V. V. Punga, et al.
Published: (2016-09-01)

MOLECULAR GENETIC ANALYSIS AND SPECTRUM OF MUTATIONS IN KATG, INHA, RPOB GENES CODING DRUG RESISTANCE TO ISONIAZID AND RIFAMPICIN IN THOSE SUFFERING FROM TB/HIV CO-INFECTION
by: T. Yu. Salina, et al.
Published: (2016-08-01)

MANAGEMENT OF PREGNANCY, DELIVERY AND POST-NATAL PERIOD IN THE PATIENT WITH DRUG RESISTANT DESTRUCTIVE PULMONARY TUBERCULOSIS AFTER SEVERAL SURGERIES
by: S. I. Kayukova, et al.
Published: (2018-07-01)

CLINICAL PRESENTATION, DIAGNOSIS, AND TREATMENT IN PATIENTS WITH HIV INFECTION IN THE REPUBLIC OF ARMENIA
by: M. D. Safaryan, et al.
Published: (2014-06-01)

ANALYSIS OF THE PATIENTS REFERRED FOR TREATMENT TO NOVOSIBIRSK TUBERCULOSIS RESEARCH INSTITUTE FROM THE AREAS SUPERVISED BY THIS INSTITUTE. CHANGES IN CHEMOTHERAPY EFFICIENCY AFTER INTRODUCTION OF THE UPDATED TREATMENT REGIMENS AND MICROBIOLOGICAL DIAGNOSTICS
by: E. P. Myshkova, et al.
Published: (2017-09-01)

MDR tuberculosis and HIV infection in the North-Western Federal District
by: Z. M. Zagdyn, et al.
Published: (2021-02-01)

Represented results tuberculosis lung patients with firsting MDR in Republic of Buryatia
by: S. V. Nikolayeva, et al.
Published: (2012-08-01)

CLINICAL CASE OF EFFECTIVE HOLISTIC TREATMENT OF BILATERIAL FIBROUS CAVERNOUS PULMONARY TUBERCULOSIS
by: G. Yu. Marfina, et al.
Published: (2017-03-01)

Short course chemotherapy in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkina, et al.
Published: (2020-12-01)

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

CHANGES IN THE PREVALENCE OF DRUG RESISTANT TUBERCULOSIS
by: V. B. Galkin, et al.
Published: (2017-03-01)

EFFICIENCY OF VALVE BRONCHIAL BLOCK WITHIN COMPREHENSIVE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: K. D. Erimbetov, et al.
Published: (2018-05-01)

A tuberculosis infection focus and its value in the development of tuberculosis in children
by: V. A. Aksenova, et al.
Published: (2015-01-01)

GENETIC CHARACTERISTICS AND DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN PATIENTS WITH TUBERCULOSIS AND HIV INFECTION IN THE IRKUTSK REGION
by: E. Yu. Zorkaltseva, et al.
Published: (2014-06-01)

TYPICAL FEATURES OF PRIMARY DRUG RESISTANCE AND VIABILITY OF MYCOBACTERIA IN TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION
by: N. M. Koretskaya, et al.
Published: (2017-02-01)

Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
by: E. V. Vаniev, et al.
Published: (2018-11-01)

Speciﬁc course of COVID-19 associated pneumonia in the tuberculosis patient after pleuropneumonectomy
by: E. M. Zhukova, et al.
Published: (2022-06-01)

DRUG RESISTANCE OF STRAINS OF M. TUBERCULOSIS, ISOLATED FROM PULMONARY TUBERCULOSIS PATIENTS IN VLADIMIR REGION IN 2013
by: E. S. Dyuzhik, et al.
Published: (2015-10-01)

TUBERCULOSIS IN SIBERIAN AND FAR EASTERN FEDERAL DISTRICTS (2007-2016)
by: T. V. Alekseeva, et al.
Published: (2017-09-01)

A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance
by: P. N. Golubchikov, et al.
Published: (2020-07-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

Surgical treatment of patients with HIV-associated respiratory tuberculosis and diﬀerent immune status
by: S. N. Shugaeva, et al.
Published: (2021-11-01)

EFFICIENCY OF ADDING AN IMMUNE RESTORATIVE AGENT TO THE CURRENT TREATMENT REGIMENS OF PULMONARYTUBERCULOSIS PATIENTS WITH DRUG RESISTANCE
by: E. M. Zhukovа, et al.
Published: (2018-01-01)

Experience of application of antitubercular and anti-retrovirus therapy at patients with tuberculosis with HIV infection
by: A. V. Mordyk, et al.
Published: (2014-10-01)

Social aspects multi-drug resistant tuberculosis
by: O. V. Filinyuk, et al.
Published: (2012-08-01)